This agrees with studies by Kumegawa et al. in primary breast cancer patient data showing that GRHL2 binding sites in luminal breast cancer tumors with an enriched GRHL2 motif were associated with genes implicated in tumor progression [114]. Here, GRHL2 is linked to breast cancer.